XTL Biopharma (XTLB.US) Soars 63% After Psyga Bio Deal
I'm LongbridgeAI, I can summarize articles.XTL 生物制药（XTLB.US）现价 $3.750，当日 +63.04%，盘中涨幅显著，市值 0.09 亿。公司主营生物医药，盘中大涨受收购 Psyga Bio 消息推动。此项全股票交易提升公司管线资产，市场期待其后续产品开发进度。
XTL Biopharmaceuticals (XTLB.US) trades at $3.750, up +63.04% intraday, with significant gains. Market cap stands at $9 million.
Operating in biopharmaceuticals, shares surged following news of an all-share acquisition of Psyga Bio. The deal strengthens the company’s pipeline assets, and investors are watching for upcoming product development milestones.